Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
Neurourology and Urodynamics|December 1, 2020
Polypropylene and polyvinylidene fluoride transobturator slings for the treatment of female stress urinary incontinence: 1-Year outcomes from a multicentre randomized trialJordi Sabadell, Anna Pereda-Núñez, Fernando Ojeda-de-Los-Santos, et al.
JAMA Oncology|August 30, 2019
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical TrialCarlos Fernández-Martos, Carles Pericay, Ferran Losa, et al.
Plos One|October 10, 2022
The COVID-19 pandemic effect on the prehospital Madrid stroke code metrics and diagnostic accuracyNicolás Riera-López, Andrea Gaetano-Gil, José Martínez-Gómez, et al.
ACS Omega|August 29, 2019
Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N,N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer ModelsVeronica Corrales Sánchez, Cristina Nieto-Jiménez, José Antonio Castro-Osma, et al.
Archivos De Bronconeumologia|June 15, 2022
Health outcomes: Towards the accreditation of respiratory medicine departmentsJosé Manuel Álvarez-Dobaño, Gerardo Atienza, Carlos Zamarrón, et al.
Archivos De Bronconeumologia|March 8, 2021
Health Outcomes: Towards the Accreditation of Respiratory Medicine DepartmentsJosé Manuel Álvarez-Dobaño, Gerardo Atienza, Carlos Zamarrón, et al.
Heart & Lung : the Journal of Critical Care|July 3, 2022
Sarcoidosis. Disease progression based on radiological and functional course: Predictive factorsAna Casal, Juan Suárez-Antelo, Roi Soto-Feijóo, et al.
The Oncologist|March 28, 2025
Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospitalAntonio Rueda-Lara, David Viñal, Daniel Martínez-Pérez, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2022
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 studyMarta Español-Rego, Carlos Fernández-Martos, Elena Elez, et al.
Journal of the National Cancer Institute|July 5, 2023
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402David Pesántez, Sanne Ten Hoorn, Isidro Machado, et al.
Pageof 26